[1]
Sunkara, R. and Chimakurthy, J. 2026. A Systems Pharmacology Study on Lanifibranor for the Management of Non-Alcoholic Fatty Liver Disease. Current Trends in Biotechnology and Pharmacy. 20, 2A (May 2026), 174–189. DOI:https://doi.org/10.5530/ctbp.2026.2s.14.